Use of neuromonitoring in cervical spine surgery varies significantly across the US and around the world. In some regions, multimodality neuromonitoring is used routinely for all procedures. In other regions, it’s rarely used at all. In this episode, Dr. Todd Albert is interviewed for his perspective as an orthopedic spine surgeon.

Disclosures:

Albert, Todd J.: Board of Directors: American Orthopaedic Association (Nonfinancial, Treasurer-Elect), Hospital For Special Surgery (None, Surgeon-in-Chief Emeritus and Medical Director), Scoliosis Research Society (Nonfinancial, Past President); Consulting: Nuvasive (B); Other: JP Medical Publishers (B), Saunders/Mosby- Elsevier (B), Springer (A), Thieme Medical Publishers (B); Research Support (Staff and/or materials): PCORI (D); Royalties: DePuy Synthes Spine (F); Stock Ownership: ASIP (D), Augmedics (F), Biomerix (D, 42,253 Shares), Bonovo Orthopedics (D, 85,737 Shares), Crosstrees Medical  (D,  <1%), Cytodyn Inc. (F), Gentis (D), Innovative Surgical Designs (F), InVivo Therapeutics (C, <1%. Advisory Board, Stock options.), Invuity  (C, <1%. Member of Advisory Board, stock options.), Morphogenesis (E), Paradigm Spine, LLC (F, <1%.), Physician Recommended Nutriceuticals (D), PMIG (D), Pulse Equity (F), Spinicity  (D, <1%.), Strathspey Crown (F), Surg.IO (E), Vital 5 (None, <1%. Advisory Board, Stock Holder), Zimmer Biomet  (F).

Doan, Adam: Other: Nuvasive Clinical Services  (Salary); Private Investments: Veridical RCM (D). 

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+